ニュージャージーにおける子宮内膜がんの臨床試験
ニュージャージー内の拠点で、子宮内膜がんに関する32件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Hunterdon Medical Center, Flemington
- Monmouth Medical Center Southern Campus, Lakewood
- Cooperman Barnabas Medical Center, Livingston
- 他6件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooperman Barnabas Medical Center, Livingston
- Memorial Sloan Kettering Monmouth, Middletown
- 他6件
被験者募集中第3相
18歳以上 · 女性 · 2026/10/02更新 · NCT07198074A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activites), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
被験者募集中
18歳以上 · 女性 · 2026/09/25更新 · NCT07270666Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Sidney Kimmel Cancer Center Washington Township, Sewell
被験者募集中第2相
18歳以上 · 女性 · 2026/09/24更新 · NCT05640999Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, East Brunswick
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Morristown Medical Center, Morristown
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07262619A Study of Ivonescimab in People With Endometrial and Cervical Cancers
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
被験者募集中第2相
18歳以上 · 女性 · 2026/09/21更新 · NCT06925724A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Holy Name Medical Center ( Site 6011), Teaneck
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT06952504PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Virtua Health, Voorhees Township
被験者募集中第2相
18歳以上 · 女性 · 2026/09/17更新 · NCT05758688ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- START - New Jersey, East Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Morristown Medical Center, Morristown
- Atlantic Health - Overlook MC, Summit
- Holy Name Medical Center, Teaneck
被験者募集中第3相
18歳以上 · 女性 · 2026/09/09更新 · NCT07166094DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Hackensack
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06989112A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START New Jersey, LLC, East Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07383506Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack
被験者募集中第1相
15歳以上 · 全性別 · 2026/08/25更新 · NCT06276491A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of NJ, New Brunswick
被験者募集中第2相
18歳以上 · 女性 · 2026/08/21更新 · NCT05548296A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
被験者募集中観察研究
18歳以上 · 女性 · 2026/08/07更新 · NCT04291612Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07444814Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Camden
- Research Site, Paramus
被験者募集中第3相
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
被験者募集中第2相
18歳以上 · 女性 · 2026/07/16更新 · NCT07209449Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
- Memorial Sloan Kettering Basking Ridge (All Protocol Activites), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
被験者募集中第2相
18歳以上 · 女性 · 2026/07/09更新 · NCT04774419Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
- Rutgers Cancer Institut Jersey, New Brunswick
被験者募集中
18歳〜90歳 · 女性 · 2026/07/06更新 · NCT07643012A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
被験者募集中早期第1相
18歳以上 · 女性 · 2026/06/25更新 · NCT05691010A Study of LY4175408 in Participants With Advanced Cancer
- John Theurer Cancer Center At Hackensack UMC, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
被験者募集中早期第1相
18歳以上 · 女性 · 2026/04/13更新 · NCT06751589A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
- Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
被験者募集中
18歳以上 · 女性 · 2026/01/06更新 · NCT07318415SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。